Regis Technologies, a contract manufacturing organization (CMO), announced that Wayne Nowicki, director of business development for the company, unveiled the details of its Potent Compound Suite (PCS) at a press conference held on Feb. 3, 2015. An expansion to the company s Morton Grove,Original Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.